Therapeutic Analysis Of Transarterial Infusion Chemotherapy Of Gemcitabline For Post Radical Operation In Patients With Cancer Of Pancreatic Head

Objective To investigate the clinic value of transarterial infusion chemotherapy ofgemcitabine for post radical excision in patients with cancer of pancreatic head.Methods 66 patients with cancer of pancreatic head were divided to the controlgroup (32 patients) and the therapeutic group (34 patients). The control groupreceived traditional vein chemotherapy of gemcitabine while the therapeutic groupreceived transarterial infusion chemotherapy of gemcitabine. The incidence rate ofadverse event, the liver metastasis rate, local recurrence rate and survival time werecompared between the two groups after operation.Results 1) according to the stage standard of WHO, the incidence rate of thedecreace of blood cell in the control group is significantly higher than the therapeuticgroup(P<0.05); 2) the liver metastasis rate, local recurrence rate and survival time in1 year and 3 years are individually 17%, 42% and 44%, 11% in the therapeutic groupwhile in the control group the liver metastasis rate, local recurrence rate and survivaltime in 1 year and 3 years are individually 73%, 68% and 16%, 3%. There issignificantly statistical difference between the two groups(P<0.05).Conclusion transarterial infusion chemotherapy of gemcitabine for post radicalexcision in patients with cancer of pancreatic head can improve the survival quality ofpatients, prevent recurrence and prolong the survival period of patients.